New study [1].
I have used a nitroglycerine patch for several years. The idea is to help improve blood flow to tumors. When the oxygen supply is poor, PCa cells will respond with Hypoxia-inducible factor 1-alpha [HIF1alpha]. HIF1alpha is implicated in treatment resistance & it makes cells more aggressive. The patch releases nitric oxide [NO] which dilates blood vessels. In spite of those who believe that "cancer hates oxygen", tumors want to have a good supply. A key role of HIF1alpha is to stimulate creation of blood vessels via VEGF (vascular endothelial growth factor).
For some reason, Arora & Ramasamy figured that NO might be useful in CRPC control. They used GSNO (S-nitrosoglutathione) [2] to increase NO levels & used human tumor xenografts containing ARV-7 cells in an animal model.
"The study found the compound suppressed these tumors and continued to suppress them with no signs of resistance. The increased NO helped neutralize the tumor microenvironment — the complex, inflammatory shell around which tumors grow. Specifically, GSNO reduced levels of tumor-associated macrophages, immune cells that cancers co-opt into their microenvironment."
-Patrick
{I was unable to locate the paper on the Proceedings of the National Academy of Sciences [PNAS] site.}